Health Investment Returns: Harnessing Health as...

By João L. Carapinha

November 18, 2025

Health as a Strategic Economic Imperative A country's enduring strength stems not solely from military or industrial resources but from the vitality and productivity of its populace. A recen...
Rethinking Health Technology Assessment: Evolving Economic Evaluations for Fa...
TAVI Cost-Effectiveness in Brazil: Balancing Coverage Expansion and Economic ...
Key Decisions on Health Technology Assessment at ACP124: Implications for Rar...
NICE HealthTech Methods Update
Revolutionizing Pharmacoeconomic Evaluations Nederland: Zorginstituut’s...
Model Type and Its Impact on Pneumococcal Vaccine Cost-Effectiveness in Germany
NICE’s Ribociclib Breast Cancer Guidance: A New Era for High-Risk Patie...
Talquetamab Multiple Myeloma: Impact, Evidence, and Policy Considerations
NICE Rejects Donanemab: Treatment Cost-Effectiveness
Future-Proofing Hospitals: Singapore’s Blueprint for Smarter Healthcare
NICE HealthTech Reforms: Accelerating Digital Innovation in NHS and Global He...
Business Dynamics: How Novo Nordisk Lost GLP-1 Market Share